Healtcare MAGAZINE
OVERALL SITUATION AND LEADERSHIP CHANGES
From our privileged vantage point, we are analyzing how changes in the Life Sciences sector are reshaping corporate governance, leadership priorities, and the skillsets required of today’s managers.
Innovation within the healthcare ecosystem is accelerating, driven by advances in genomics, gene therapy, synthetic biology, and artificial intelligence.
Competitive pressures are influencing corporate strategies, leading to greater investment in generics and biosimilars, pricing and market access management, faster and more cost-effective market entry, and increased M&A activity.
These topics will be explored in depth in this and upcoming issues through dedicated articles. In this edition, we focus on the evolution of the CDMO sector, the role of Foundations, changes in R&D processes, and highlight emerging trends and market insights.